ENTITY
CanariaBio

CanariaBio (016790 KS)

19
Analysis
Consumer StaplesSouth Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
Publication Icon
No publications yet
There aren’t any Insights right now
Back to "All"
x